Monzer H Yazji MD & Associates PLLC
Monzer H Yazji MD & Associates PLLC was paid $4.45M by Medicaid between Jan 2018 and Dec 2024, across 134 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoMONZER H YAZJI MD & ASSOCIATES PLLC
EDINBURG, TX 78539
EDINBURG, TX 78539
33aNPI1073508545assigned 09/12/2005
33bProvider typeChiropractor
28Total paid$4.45M
24GClaims203,161
24DCodes billed134
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Chiropractor providers in Texas
Rank by total paid#1 of 67
Median peer was paid$13K
This provider vs. median338×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,791 | $169K | |
| 2019 | 11,447 | $151K | |
| 2020 | 18,430 | $248K | |
| 2021 | 36,364 | $986K | |
| 2022 | 52,091 | $1.15M | |
| 2023 | 44,170 | $944K | |
| 2024incomplete | 27,868 | $804K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 40,343 | 34,062 | $1.26M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 29,012 | 26,542 | $805K |
| 95813 | 13% | 1,873 | 1,854 | $576K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 11% | 4,201 | 4,148 | $505K |
| 95713 | 7.9% | 666 | 655 | $351K | |
| 99444 | 5.1% | 3,999 | 1,050 | $229K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.6% | 3,296 | 2,675 | $115K |
| 95718 | 1.9% | 811 | 796 | $84K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.3% | 4,661 | 4,317 | $57K |
| 99422 | 1.1% | 2,163 | 565 | $48K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,434 | 7,066 | $42K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,720 | 3,979 | $37K |
122 more codes
| 80061 | Lipid panel | <1% | 6,761 | $32K |
| 99254 | <1% | 265 | $32K | |
| 84439 | <1% | 6,236 | $23K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,823 | $23K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,477 | $23K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,602 | $18K |
| 80076 | <1% | 4,957 | $15K | |
| 80050 | General health panel | <1% | 513 | $15K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 213 | $13K |
| 82043 | <1% | 3,836 | $11K | |
| 82607 | <1% | 1,739 | $10K | |
| 82570 | <1% | 3,790 | $9K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,059 | $9K |
| 99349 | <1% | 723 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 677 | $8K |
| 83721 | <1% | 5,704 | $7K | |
| 81001 | <1% | 4,714 | $7K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 152 | $7K |
| 99490 | Ccm add 20min | <1% | 2,627 | $6K |
| 99091 | <1% | 54 | $6K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,256 | $5K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,193 | $5K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 90 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 408 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 82 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 126 | $3K |
| 84403 | <1% | 243 | $3K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 154 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 101 | $2K |
| 90756 | <1% | 263 | $2K | |
| 99497 | <1% | 465 | $2K | |
| 90674 | <1% | 332 | $2K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 432 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,163 | $1K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 24 | $1K |
| 94010 | <1% | 99 | $1K | |
| 84153 | <1% | 238 | $1K | |
| 97124 | <1% | 96 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 18 | $1K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 133 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 150 | $1K |
| 99350 | Prolong home eval add 15m | <1% | 89 | $1K |
| 92250 | <1% | 49 | $997.58 | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 172 | $936.37 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 12 | $871.29 |
| 99223 | Prolong inpt eval add15 m | <1% | 105 | $806.91 |
| 99457 | <1% | 512 | $763.04 | |
| 87428 | <1% | 34 | $513.72 | |
| 90785 | <1% | 309 | $493.92 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 49 | $343.02 |
| J2010 | Injection, lincomycin hcl, up to 300 mg | <1% | 34 | $313.85 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 14 | $304.81 |
| 93922 | <1% | 74 | $281.56 | |
| 84550 | <1% | 141 | $255.50 | |
| 95923 | <1% | 20 | $238.63 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 840 | $235.76 |
| 90656 | <1% | 13 | $186.95 | |
| 85651 | <1% | 80 | $179.50 | |
| 84436 | <1% | 65 | $178.87 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 14 | $160.94 |
| 96136 | <1% | 99 | $139.81 | |
| 99458 | <1% | 128 | $115.32 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 926 | $111.30 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 16 | $57.38 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 563 | $36.69 |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,890 | $29.99 |
| 94760 | <1% | 920 | $26.97 | |
| 84100 | <1% | 82 | $20.35 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 71 | $18.13 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 1,102 | $0.00 |
| 1160F | 0% | 1,402 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 94 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 337 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 168 | $0.00 |
| 1159F | 0% | 1,195 | $0.00 | |
| 3078F | 0% | 776 | $0.00 | |
| 1158F | 0% | 32 | $0.00 | |
| 0518F | 0% | 114 | $0.00 | |
| 3288F | 0% | 198 | $0.00 | |
| 1090F | 0% | 14 | $0.00 | |
| 4040F | 0% | 86 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 261 | $0.00 |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | 0% | 73 | $0.00 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 32 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 37 | $0.00 |
| 3077F | 0% | 53 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 46 | $0.00 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 24 | $0.00 |
| 4004F | 0% | 30 | $0.00 | |
| 96160 | 0% | 12 | $0.00 | |
| 99310 | Prolong nursin fac eval 15m | 0% | 13 | $0.00 |
| 1111F | 0% | 129 | $0.00 | |
| 1101F | 0% | 658 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 371 | $0.00 |
| 3044F | 0% | 956 | $0.00 | |
| 1170F | 0% | 288 | $0.00 | |
| 1126F | 0% | 737 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 630 | $0.00 |
| 1125F | 0% | 1,080 | $0.00 | |
| 3074F | 0% | 806 | $0.00 | |
| 4010F | 0% | 12 | $0.00 | |
| 3008F | 0% | 776 | $0.00 | |
| 1157F | 0% | 32 | $0.00 | |
| 1036F | 0% | 306 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 337 | $0.00 |
| 99406 | 0% | 44 | $0.00 | |
| 99000 | 0% | 15 | $0.00 | |
| 99439 | 0% | 209 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 381 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 114 | $0.00 |
| 3079F | 0% | 199 | $0.00 | |
| 3075F | 0% | 130 | $0.00 | |
| G8450 | Beta-blocker therapy prescribed | 0% | 14 | $0.00 |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 138 | $0.00 |
| 96156 | 0% | 13 | $0.00 | |
| 3017F | 0% | 32 | $0.00 | |
| 3080F | 0% | 27 | $0.00 | |
| 82040 | 0% | 27 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 55 | $0.00 |
| G8866 | Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal) | 0% | 14 | $0.00 |
| 90887 | 0% | 27 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYAZJI, MONZER (MEDICAL DOCTOR/OWNER)